Chad Spooner
Known title: EVP, Chief Financial OfficerCIK: 0002111465
Associated companies
Transaction History
| MMED | ▼ Sell | Tax Withholding | 23,301 | $412K | 7/28/2026 | View on chart |
| MMED | ▲ Buy | Grant | 94,550 | $0 | 7/1/2026 | View on chart |
| MMED | ▲ Buy | Grant | 22,057 | $0 | 7/1/2026 | View on chart |
| MMED | ▲ Buy | Grant | 70,896 | — | 3/11/2026 | View on chart |
| MMED | ▲ Buy | Grant | 70,896 | — | 3/11/2026 | View on chart |
| MMED | ▲ Buy | Grant | 127,609 | — | 3/11/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
MiniMed Set for Medtronic Split-Off, Analysts Set New Targets
Medtronic has finalized the exchange ratio for the MiniMed split-off, a key corporate event for the stock. Meanwhile, Mizuho raised its price target to $28, while Barclays initiated coverage with a lower target of $22. Recent studies also highlighted that responding to MiniMed's diabetes alerts is linked to better glucose outcomes.
MiniMed Set for Medtronic Split-Off, Analysts Set New Targets. Medtronic has finalized the exchange ratio for the MiniMed split-off, a key corporate event for the stock. Meanwhile, Mizuho raised its price target to $28, while Barclays initiated coverage with a lower target of $22. Recent studies also highlighted that responding to MiniMed's diabetes alerts is linked to better glucose outcomes.